• NETs Activate cGAS–STING in Surgical Brain Injury

  2026-08-31

  A 2024 rat study identifies neutrophil extracellular traps (NETs) as upstream drivers of surgical brain injury through activation of the cGAS–STING pathway. NET disruption reduced inflammation, edema, neuronal death, and neurological impairment, while cGAMP restored pathway activity and weakened the protective effect of DNase I.

• KPT-330: CRM1 Inhibition Beyond Cancer

  2026-08-31

  KPT-330 (Selinexor) is a selective CRM1 inhibitor best known for oncology research, but new evidence extends its relevance to osteoclast-driven osteoarthritis. This article connects nuclear export biology with bone-cartilage remodeling and translates the findings into practical assay decisions.

• Hexa His tag peptide: Cleaner His-Protein Elution

  2026-08-30

  Hexa His tag peptide enables antibody-competitive elution of His-tagged proteins while reducing antibody heavy- and light-chain carryover. This guide connects clean immunoprecipitation, interaction analysis, workflow optimization, and practical troubleshooting for bead-based and conventional anti-His assays.

• AMPK–SQSTM1 Feedback Loop in Metabolic Stress

  2026-08-29

  The 2024 Autophagy study identifies a double-positive feedback loop in which metabolic stress activates SQSTM1/p62 and AMPK, while AMPK activity further increases SQSTM1 expression and phosphorylation. This circuit coordinates KEAP1 degradation, NFE2L2/NRF2 activation, and lysosomal AMPK signaling, clarifying how tumor cells maintain antioxidant capacity during nutrient and oxidative stress.

• Hexa His Tag Peptide: A Smarter Elution Guide

  2026-08-28

  The Hexa His tag peptide enables selective, antibody-free recovery of His-tagged proteins from immunoprecipitation workflows. This guide explains its competitive mechanism, distinguishes it from IMAC elution, and connects assay design to mechanistic lessons from CARMIL actin-regulation research.

• When Sodium Stress Collapses Mitochondrial Energy

  2026-08-28

  A mechanistic and translational guide to using TMRE mitochondrial membrane potential measurements to connect sodium-driven energy failure with mitochondrial dysfunction, apoptosis research, and experimental decision-making.

• BIRB 796: Reading p38α Inhibition in Context

  2026-08-27

  BIRB 796 (Doramapimod) is a highly selective allosteric p38α inhibitor for dissecting inflammatory signaling, cytokine production, and apoptosis. This article explains how conformational control and phosphatase-dependent dephosphorylation should shape modern assay design.

• sEV CD147 Links HCC Diagnosis to PI3K/Akt Angiogenesis

  2026-08-27

  Huang et al. identify CD147-positive small extracellular vesicles as a circulating signal associated with hepatocellular carcinoma and show that these vesicles stimulate endothelial angiogenesis through PI3K/Akt-dependent VEGFA regulation. The study connects a potential liquid-biopsy marker with a functional tumor–vascular mechanism, while also defining experimental considerations for validating extracellular-vesicle signaling.

• PPT: An ERα Perturbation Tool for LUAD

  2026-08-26

  PPT (Propyl Pyrazole Triol) is a highly selective ERα agonist for separating receptor-specific estrogen signaling from correlated cancer biomarkers. This article develops a practical perturbation framework for studying ERα–FOXM1 relationships in female lung adenocarcinoma and related breast cancer research.

• ML-7 Hydrochloride in Translational Cardiac Research

  2026-08-26

  ML-7 hydrochloride is more than a pathway inhibitor: it is a mechanistic perturbation tool for connecting myosin light chain phosphorylation with cardiomyocyte injury, contractility, metabolism, and endothelial barrier behavior. This thought-leadership guide shows how to position MLCK inhibition within rigorous ischemia/reperfusion injury research and translational assay design.

• Ciprofloxacin hydrochloride: Single-Cell Workflows

  2026-08-25

  Build more informative antibacterial assays with Ciprofloxacin hydrochloride by combining concentration-controlled exposure, nutrient-aware analysis, and single-cell tracking. The workflow distinguishes DNA-damage-driven killing from apparent combination effects, helping researchers interpret ciprofloxacin–tetracycline antagonism and optimize follow-up experiments.

• EZ Cap™ Firefly Luciferase mRNA: Reliable Assays

  2026-08-25

  Learn how EZ Cap™ Firefly Luciferase mRNA (SKU R1018) can improve reporter-based workflows for viability, proliferation, cytotoxicity, delivery, and gene regulation studies. This scenario-driven guide connects Cap1 design, poly(A) tailing, RNase-safe handling, and LNP-related variables to practical assay decisions.

• Lactate Workflows for Metabolic–Immune Research

  2026-08-24

  Build reproducible L-lactate experiments that connect glycolytic output with hypoxia, mitochondrial stress, and immune signaling. This practical workflow uses extracellular and intracellular measurements to interrogate the NAT1–ENO1–lactate axis and PD-L1 regulation.

• Tetrahydromagnolol: A Receptor-Network Lens

  2026-08-24

  Tetrahydromagnolol provides a selective pharmacological entry point for cannabinoid receptor research. This article connects CB2 and GPR55 assay logic with GPCR-controlled cytoskeletal signaling while defining what the evidence does—and does not—support in cancer and inflammation models.

• Q-VD-OPh Workflows for Apoptosis Research

  2026-08-23

  Q-VD-OPh is a cell-permeable pan-caspase inhibitor for separating caspase execution from upstream stress, survival, and reprogramming. This guide translates its use into reproducible workflows for apoptosis research, post-cryopreservation recovery, and mechanistic studies of prometastatic cell states.

8493 records 1/567 page Next 12345 下5页 Last page